Welcome to the MarketReader Minute.

Below are AI-generated insights on today's premarket moves, powered by MarketReader technology.

Tuesday, October 06

Noteworthy macro moves today: EUR/USD +0.4%. GBP/USD +0.4%. US 10Y Treasury Bond Index +0.3%. Noteworthy US mega-cap moves today: Exxonmobil Holdings Corp (XOM) -1.1%. Chevron Corp (CVX) -0.9%. AbbVie Inc (ABBV) -0.6%.

Global equity markets are trading higher, with U.S., European, and Asian indices all showing gains despite the closure of cash markets in China for a public holiday today. The positive sentiment follows a strong performance on Wall Street, where the Nasdaq Composite reached a record high amid optimism surrounding technology stocks and easing crude oil prices.

In the U.S., key economic data released today showed exports rose to $315.2 billion for August, while the trade deficit widened to $105.6 billion, exceeding market expectations of $102 billion due to a significant increase in imports which surged to $420.8 billion during the same period.

In Europe, economic indicators reflected mixed results; Germany's factory orders plummeted by 10.6%, significantly worse than forecasts of a 1% decline, indicating potential weakness in industrial demand amid ongoing geopolitical tensions and rising costs from inflationary pressures.

Additionally, France's industrial production fell by 0.3%, missing expectations for growth and highlighting concerns about consumer spending amidst fiscal challenges as indicated by a widening budget deficit of €159.6 billion reported today.

Vanguard FTSE Europe ETF (VGK) [+1.1%]
SAP highlighted its advancements in AI and announced an acquisition aimed at enhancing its enterprise solutions, contributing to strong performances from key holdings including AstraZeneca, HSBC, and BBVA. AstraZeneca announced the opening of a new research and development center in Massachusetts. These developments reflect positive growth prospects in the healthcare and technology sectors. The Vanguard FTSE Europe ETF is gaining in pre-market trading, amid broader positive sentiment across global equity indices following easing concerns about interest rates after weaker-than-expected job growth data.

iShares Biotechnology ETF (IBB) [+1.0%]
The iShares Biotechnology ETF is advancing in pre-market trading, driven by notable gains in several of its holdings. Illumina and Amgen both posted significant increases, while Natera's announcement of a new clinical trial contributed to its rise. Additionally, Incyte received regulatory approval for a new treatment in Brazil, further enhancing the sector's performance. The ETF is trading higher since Monday's close and is positioned well above its 20-day moving average, indicating strong performance relative to recent trends.

State Street Energy Select Sector SPDR ETF (XLE) [-1.0%]
The State Street Energy Select Sector SPDR ETF is experiencing a modest decline in pre-market trading, driven by falling oil prices. Key holdings such as ExxonMobil, Valero Energy, ConocoPhillips, and Phillips 66 have all traded lower, influenced by a recovery of Middle Eastern oil exports toward pre-war levels and an announcement from G7 countries to release 100 million barrels from emergency reserves over the next four months. Additionally, Saudi Aramco has significantly cut its November official selling prices for crude oil bound for Asia. These factors are contributing to the fund's downward movement as the energy sector adjusts to shifting dynamics.

CEG | +9.4% | +9.9B
Constellation Energy Corp | Utilities
Constellation Energy Corp has entered a landmark 20-year power purchase agreement with Google to enhance the PJM Interconnection grid by adding 890 megawatts of nuclear capacity through upgrades at 11 reactors. The initiative, backed by over $4.3 billion in investment, is expected to sustain approximately 4.4k existing jobs and create around 7.2k construction jobs. Additionally, the collaboration includes a five-year technology alliance to implement AI solutions aimed at improving efficiency and reliability in energy operations. In pre-market trading, Constellation Energy's shares are sharply higher since Monday's close, reflecting positive market sentiment surrounding this significant partnership.

VST | +4.6% | +2.4B
Vistra Corp | Utilities
Vistra Corp has received a conditional loan commitment of $4.2 billion from the U.S. Department of Energy to modernize its nuclear facilities, including Beaver Valley, Davis-Besse, and Perry. This funding is expected to enhance power production capacity by 433 megawatts and create approximately 3k jobs. Following the announcement, retail sentiment around Vistra was described as "extremely bullish," with significant social media engagement noted. In pre-market trading, the stock is advancing sharply, amid broader positive market movements.

ZS | +2.4% | +0.8B
Zscaler Inc | Information Technology
Zscaler Inc's stock is advancing following the company's reaffirmation of its financial guidance during its Investor Day. The firm expects first-quarter revenue between $935 million and $939 million, with non-GAAP earnings per share projected at $1.15 to $1.16. For fiscal 2027, Zscaler anticipates annual recurring revenue of $4.396 billion to $4.426 billion and total revenue of $3.908 billion to $3.938 billion, reflecting growth rates of approximately 16.6% to 17.5%. CEO Jay Chaudhry emphasized the relevance of Zscaler’s Zero Trust architecture in addressing current security challenges, particularly related to AI threats. In pre-market trading, Zscaler's shares are higher, continuing a notable increase from after-market hours on Monday.

PCVX | -2.3% | -0.2B
Vaxcyte Inc | Health Care
Vaxcyte Inc has announced the launch of dual public offerings totaling $1 billion, which includes $500 million in common stock and pre-funded warrants, along with $500 million in convertible senior notes due 2032. The company stated that these offerings are contingent on market conditions, with no guarantee of completion, size, or terms. The proceeds will be allocated towards the clinical development of its VAX-31 programs, manufacturing scale-up, and general corporate purposes. Following this announcement, shares of Vaxcyte have declined during pre-market trading.

RPM | -0.4% | -0.0B
RPM International Inc | Materials
RPM International Inc. reported its fiscal 2027 first-quarter results, revealing record sales of $2.22 billion, a 4.8% year-over-year increase, but falling short of analysts' expectations of $2.23 billion. Net income rose to $256.4 million, with adjusted earnings per share (EPS) of $1.98, exceeding the consensus estimate of $1.95. The company issued a conservative outlook, projecting second-quarter sales growth in the low- to mid-single-digit range and revising its full-year sales growth forecast down to a mid-single-digit increase from a previous estimate of 3% to 7%. Following the mixed earnings results and cautious guidance, RPM's shares declined in pre-market trading.

Thank you for spending a minute with us.

If you have 2 more minutes, watch this demo of the MarketReader Platform: